By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Carlsmed, Inc.

Carlsmed, Inc. (CARL)

NASDAQ Market Data in USD
$460.00
+$1.66
+0.36%
Last Update: 18 Jul 2026, 03:24
$0.00
Market Cap
P/E Ratio (TTM)
Forward Dividend Yield
$314.88-$614.20
52 Week Range

CARL Stock Price Chart

Explore Carlsmed, Inc. interactive price chart. Choose custom timeframes to analyze CARL price movements and trends.

CARL Company Profile

Discover essential business fundamentals and corporate details for Carlsmed, Inc. (CARL) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

23 Jul 2025

Employees

127.00

CEO

Michael Cordonnier

Description

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

CARL Financial Timeline

Browse a chronological timeline of Carlsmed, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 27 Aug 2026

EPS estimate is -$0.32, while revenue estimate is $18.96m.

Upcoming earnings on 21 Jul 2026

EPS estimate is -$0.43, while revenue estimate is $17.95m.

Earnings released on 5 May 2026

EPS came in at -$0.32 surpassing the estimated -$0.43 by +25.58%, while revenue for the quarter reached $16.12m , beating expectations by +7.84%.

Earnings released on 25 Feb 2026

EPS came in at -$0.32 surpassing the estimated -$0.43 by +25.58%, while revenue for the quarter reached $15.17m , beating expectations by +3.01%.

Earnings released on 6 Nov 2025

EPS came in at -$0.40 surpassing the estimated -$0.45 by +11.11%, while revenue for the quarter reached $13.07m , missing expectations by -12.01%.

Earnings released on 28 Aug 2025

EPS came in at -$1.47 surpassing the estimated -$1.52 by +3.29%, while revenue for the quarter reached $12.08m , beating expectations by +0.80%.

CARL Stock Performance

Access detailed CARL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run